Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jim Cramer - Mad Money
Gritstone OncologyGRTSCOMMENTJan 20, 2021
A biotech that's up 342% in the past week, because yesterday they announced they're working on a 2nd-generation Covid vaccine. They already an agreement with the National Institute for Allergy and Infectious Diseases to start testing it. Their immunotherapy-based vaccine could be a game-changer even in phase 1 testing.
Jim Cramer - Mad MoneyUnknown
$25.49
Stock price when the opinion was issued
$2.46
As of May 02, 2023. Market Open.
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
